The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

This new evidence review was funded by AbbVie, the maker of Qulipta. Qulipta and other CGRP-blocking drugs tend to be much more expensive than older migraine drugs, according to the Association of ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 ... Lipton, MD, of Albert Einstein College of Medicine in the Bronx, New York, in a press release. "Some people ...

Migraine is the most common neurological condition in the world, with more than one in seven people suffering from migraines ...

Now, a massive new study just dropped some serious truth ... thinks this research is going to change how doctors and patients talk about migraine treatment. Why this matters even if you don ...

Today, there are several medication options to treat migraine. Triptans are one class, or group, of medications that can treat migraine attacks after they start. Triptans cannot prevent a migraine ...

Explore the complex relationship between migraines and weather conditions like barometric pressure, sunlight and temperature, ...

Over-the-counter medications can often treat migraine symptoms. However, if your migraine symptoms persist, you may want to talk with a doctor about prescription options. Migraine is a health ...

Heat can act as both a notorious trigger or a soothing remedy for migraines. We dug into the intricate balance pain sufferers ...

In conversation with Dr Peter Goadsby, Director of NIHR Clinical Research Facility and Professor of Neurology at King's ...